Nanovibronix, Inc. (NASDAQ:FEED) Short Interest Update

Nanovibronix, Inc. (NASDAQ:FEED) was the recipient of a large decline in short interest in the month of August. As of August 31st, there was short interest totaling 87,719 shares, a decline of 74.5% from the August 15th total of 344,075 shares. Approximately 10.8% of the shares of the company are short sold. Based on an average daily trading volume, of 212,831 shares, the days-to-cover ratio is currently 0.4 days.

Insider Activity

In other news, insider Christian Michael Glibert sold 17,500 shares of the firm’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $8.28, for a total transaction of $144,900.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 12.20% of the company’s stock.

Analysts Set New Price Targets

FEED has been the subject of several recent research reports. Wall Street Zen raised shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a research report on Sunday, July 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nanovibronix in a research note on Tuesday, July 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Nanovibronix currently has an average rating of “Sell”.

Nanovibronix Stock Performance

Shares of NASDAQ FEED traded up $0.01 during midday trading on Friday, reaching $3.58. 10,931 shares of the company traded hands, compared to its average volume of 54,630. Nanovibronix has a 12 month low of $3.48 and a 12 month high of $208.80. The stock’s 50-day simple moving average is $4.69 and its 200-day simple moving average is $12.26. The firm has a market cap of $3.30 million, a PE ratio of -0.03 and a beta of 1.38.

Nanovibronix (NASDAQ:FEED) last announced its earnings results on Monday, August 17th. The company reported ($23.76) earnings per share (EPS) for the quarter. Nanovibronix had a negative return on equity of 60.73% and a negative net margin of 1,093.61%.The firm had revenue of $0.24 million for the quarter.

Nanovibronix Company Profile

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.